Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis
Main Authors: | Kelly L. Hayward, Vikas Bansal, Patricia C. Valery, Katharine M. Irvine, Penny L. Wright, Caroline J. Tallis, Katherine A. Stuart, W. Neil Cottrell, Jennifer H. Martin, Elizabeth E. Powell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-11-01
|
Series: | Hepatology Communications |
Online Access: | https://doi.org/10.1002/hep4.1999 |
Similar Items
-
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety
by: Kelly L. Hayward, et al.
Published: (2021-11-01) -
Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial
by: Kelly L. Hayward, et al.
Published: (2017-07-01) -
COVID-19 in decompensated cirrhosis
by: O. V. Tashchyan, et al.
Published: (2021-01-01) -
Management options in decompensated cirrhosis
by: Shah NL, et al.
Published: (2015-07-01) -
Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
by: William Dungan MD, et al.
Published: (2022-12-01)